Carregant...
Delayed Infusion Reactions to Enzyme Replacement Therapies
Background: There are currently ten intravenous enzyme replacement therapy (ERT) products available for the treatment of eight different lysosomal diseases (LD) in the USA. Additional ERT products are in clinical trials. The most common ERT adverse events are infusion reactions (IR). While IR are of...
Guardat en:
| Publicat a: | JIMD Rep |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5509557/ https://ncbi.nlm.nih.gov/pubmed/27557812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2016_8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|